ArticleCost effectiveness and resource allocation : C/E2018

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.

Dhvani Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.